SAFINAMIDE MESYLATE Drug Patent Profile
✉ Email this page to a colleague
When do Safinamide Mesylate patents expire, and what generic alternatives are available?
Safinamide Mesylate is a drug marketed by Aurobindo Pharma and Prinston Inc and is included in two NDAs.
The generic ingredient in SAFINAMIDE MESYLATE is safinamide mesylate. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the safinamide mesylate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Safinamide Mesylate
A generic version of SAFINAMIDE MESYLATE was approved as safinamide mesylate by PRINSTON INC on April 25th, 2024.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SAFINAMIDE MESYLATE?
- What are the global sales for SAFINAMIDE MESYLATE?
- What is Average Wholesale Price for SAFINAMIDE MESYLATE?
Summary for SAFINAMIDE MESYLATE
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 79 |
| Patent Applications: | 29 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for SAFINAMIDE MESYLATE |
| DailyMed Link: | SAFINAMIDE MESYLATE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for SAFINAMIDE MESYLATE
US Patents and Regulatory Information for SAFINAMIDE MESYLATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aurobindo Pharma | SAFINAMIDE MESYLATE | safinamide mesylate | TABLET;ORAL | 215902-001 | Jun 14, 2023 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Prinston Inc | SAFINAMIDE MESYLATE | safinamide mesylate | TABLET;ORAL | 215739-002 | Apr 25, 2024 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Aurobindo Pharma | SAFINAMIDE MESYLATE | safinamide mesylate | TABLET;ORAL | 215902-002 | Jun 14, 2023 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Prinston Inc | SAFINAMIDE MESYLATE | safinamide mesylate | TABLET;ORAL | 215739-001 | Apr 25, 2024 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
